Anika Therapeutics (ANIK) EPS (Basic) (2010 - 2025)
Anika Therapeutics (ANIK) posted quarterly EPS (Basic) of -$0.11 for Q4 2025, up 92.01% year-over-year from -$0.05 in Q4 2024, and down 279.36% quarter-over-quarter from $0.06 in Q3 2025.
Anika Therapeutics (ANIK) EPS (Basic) (2010 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has reported EPS (Basic) for 16 consecutive years, with -$0.11 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 92.01% year-over-year to -$0.11; the TTM figure through Jun 2026 stood at -$0.05 (up 98.5% YoY), while the FY2025 annual figure was -$0.06, up 98.05% from the prior year.
- EPS (Basic) retreated to -$0.11 in Q4 2025 per ANIK's latest filing, from $0.06 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.1 in Q4 2023 and bottomed at -$1.9 in Q3 2024.
- Historically, EPS (Basic) has averaged -$0.15 across 5 years, with a median of -$0.14 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 407.96% in 2022 and fell as far as 845.0% in 2022.
- Anika Therapeutics' EPS (Basic) stood at -$0.22 in 2021, then surged by 407.96% to $0.69 in 2022, then jumped by 59.67% to $1.1 in 2023, then sank by 219.21% to -$1.32 in 2024, then soared by 92.01% to -$0.11 in 2025.
- Business Quant data shows ANIK's EPS (Basic) at -$0.11 in Q4 2025, $0.06 in Q3 2025, and $0.05 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 283.53 Mn | 245.12 Mn | 21.24 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -1.32 |
| Sep 30, 2024 | -1.90 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | 1.10 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.19 |
| Mar 31, 2023 | -0.70 |
| Dec 31, 2022 | 0.69 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.20 |
| Mar 31, 2022 | -0.20 |
| Dec 31, 2021 | -0.22 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.45 |
| Mar 31, 2021 | 0.20 |